Recent News

• 05.27.2026 - Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
• 05.14.2026 - Milestone Scientific Reports Financial Results for First Quarter 2026
• 05.07.2026 - Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call
• 05.07.2026 - Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
• 04.21.2026 - Milestone Scientific Inc. Completes $2.15 Million Private Placement
• 03.31.2026 - Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025
• 03.26.2026 - Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call
• 02.23.2026 - Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
• 02.10.2026 - Objective real-time epidural pressure measurement using the CompuFlo1 device, a mono-center observational study
• 02.10.2026 - Loss-of-Resistance Versus Dynamic Pressure-Sensing Technology for Successful Placement of Thoracic Epidural Catheters: A Randomized Clinical Trial

Recent Filings

• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2026 - 8-K Current report
• 05.06.2026 - 8-K Current report
• 05.05.2026 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.23.2026 - D Notice of Exempt Offering of Securities
• 04.21.2026 - 8-K Current report
• 04.21.2026 - EX-99.1 EX-99.1
• 04.02.2026 - 8-K Current report
• 03.31.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.11.2026 - 8-K Current report